(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of -0.48% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Inogen's revenue in 2026 is $339,107,000.On average, 4 Wall Street analysts forecast INGN's revenue for 2026 to be $9,452,536,869, with the lowest INGN revenue forecast at $9,048,724,536, and the highest INGN revenue forecast at $9,766,121,978. On average, 4 Wall Street analysts forecast INGN's revenue for 2027 to be $8,964,477,790, with the lowest INGN revenue forecast at $7,845,868,223, and the highest INGN revenue forecast at $10,050,064,714.
In 2028, INGN is forecast to generate $8,732,539,219 in revenue, with the lowest revenue forecast at $8,235,899,453 and the highest revenue forecast at $9,154,553,010.